These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 34344725)
1. Chimeric non-antigen receptors in T cell-based cancer therapy. Guo J; Kent A; Davila E J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34344725 [TBL] [Abstract][Full Text] [Related]
2. Limitations in the Design of Chimeric Antigen Receptors for Cancer Therapy. Stoiber S; Cadilha BL; Benmebarek MR; Lesch S; Endres S; Kobold S Cells; 2019 May; 8(5):. PubMed ID: 31108883 [TBL] [Abstract][Full Text] [Related]
3. Strategies for enhancing adoptive T-cell immunotherapy against solid tumors using engineered cytokine signaling and other modalities. Shum T; Kruse RL; Rooney CM Expert Opin Biol Ther; 2018 Jun; 18(6):653-664. PubMed ID: 29727246 [TBL] [Abstract][Full Text] [Related]
4. T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors. Chandler NJ; Call MJ; Call ME Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050044 [TBL] [Abstract][Full Text] [Related]
5. Chimeric antigen receptor-engineered T-cell therapy for liver cancer. Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325 [TBL] [Abstract][Full Text] [Related]
6. CAR-NK Cells: From Natural Basis to Design for Kill. Khawar MB; Sun H Front Immunol; 2021; 12():707542. PubMed ID: 34970253 [TBL] [Abstract][Full Text] [Related]
7. Generation of CAR-T Cells for Cancer Immunotherapy. Xu Q; Harto H; Berahovich R; Xu S; Zhou H; Golubovskaya V; Wu L Methods Mol Biol; 2019; 1884():349-360. PubMed ID: 30465215 [TBL] [Abstract][Full Text] [Related]
8. Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer. Gorchakov AA; Kulemzin SV; Kochneva GV; Taranin AV Eur Urol; 2020 Mar; 77(3):299-308. PubMed ID: 31471138 [TBL] [Abstract][Full Text] [Related]
9. Engineering Cytoplasmic Signaling of CD28ζ CARs for Improved Therapeutic Functions. Meng X; Jing R; Qian L; Zhou C; Sun J Front Immunol; 2020; 11():1046. PubMed ID: 32636832 [TBL] [Abstract][Full Text] [Related]
10. Engineered Cytokine Signaling to Improve CAR T Cell Effector Function. Bell M; Gottschalk S Front Immunol; 2021; 12():684642. PubMed ID: 34177932 [TBL] [Abstract][Full Text] [Related]
11. Engineering CAR-T Cells for Next-Generation Cancer Therapy. Hong M; Clubb JD; Chen YY Cancer Cell; 2020 Oct; 38(4):473-488. PubMed ID: 32735779 [TBL] [Abstract][Full Text] [Related]
12. CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment. Martinez M; Moon EK Front Immunol; 2019; 10():128. PubMed ID: 30804938 [TBL] [Abstract][Full Text] [Related]
14. Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma. Makkouk A; Yang XC; Barca T; Lucas A; Turkoz M; Wong JTS; Nishimoto KP; Brodey MM; Tabrizizad M; Gundurao SRY; Bai L; Bhat A; An Z; Abbot S; Satpayev D; Aftab BT; Herrman M J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34916256 [TBL] [Abstract][Full Text] [Related]
15. Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy. Olguín-Contreras LF; Mendler AN; Popowicz G; Hu B; Noessner E Front Immunol; 2021; 12():750478. PubMed ID: 34912334 [TBL] [Abstract][Full Text] [Related]
16. Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells. Morandi F; Yazdanifar M; Cocco C; Bertaina A; Airoldi I Cells; 2020 Jul; 9(8):. PubMed ID: 32707982 [TBL] [Abstract][Full Text] [Related]
17. Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors. Kosti P; Maher J; Arnold JN Front Immunol; 2018; 9():1104. PubMed ID: 29872437 [TBL] [Abstract][Full Text] [Related]